Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Mahamaya Lifesciences starts state of the art formulation plant dedicated for Emamectin Benzoate 5% SGqrcode

Apr. 29, 2022

Favorites Print
Apr. 29, 2022

Mahamaya Lifesciences recently inaugurated state-of-the-art formulation plant dedicated for manufacturing Emamectin Benzoate 5% SG at Dahej in the state of Gujarat. The per day capacity of the newly started plant is 2 MT for SG/WG formulations and 3MT for WP/SP formulations. Mahamaya through this formulation plant aims to cater the need of its domestic (Brand and P2P) as well as export market demand of Emamectin Benzoate 5% SG.

Mahamaya has also invested in world class R&D and Quality control for process development of new generation safe formulations and few active ingredients having good global market potential.


Mahamaya Lifesciences Pvt. Ltd., was established in 2002 by an agrochemical technocrat having vast experience in this field. The company is engaged in Agrochemical manufacturing, Marketing, Exports and Imports since 2002. In the last 2 decades Mahamaya has introduced a number of potential products in Indian Market like Acetamiprid, Buprofezin, Emamectin Benzoate, Imidacloprid and Pretilachlor. Mahamaya is manufacturing and supplying a wide range of crop protection formulation in the Indian as well as global market and supporting farmers for better food production. Currently Mahamaya is operating its brand business in 6 Indian states and is exporting to 10 countries with registration expected in more countries in 2022.


More from AgroNewsChange

Hot Topic More

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  





Subscribe India Special Biweekly to send news related to your mailbox